Efficiency of Percutaneous Minimally Invasive  Technologies in the Treatment of Patients with  Obstructive Jaundice

Ergashev U.Y., Minavarkhujayev R.R., Gafurov B.T., Malikov N.M., Ortiqboyev F.D.,  Abdusalomov B.A.

dc.contributor.author	Ergashev U.Y., Minavarkhujayev R.R., Gafurov B.T., Malikov N.M., Ortiqboyev F.D., Abdusalomov B.A.
dc.date.accessioned	2023-04-27T02:25:47Z
dc.date.available	2023-04-27T02:25:47Z
dc.date.issued	2022
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/7215
dc.description.abstract	The treatment of obstructive jaundice is a complex problem in modern surgery. Progressive hepatic failure is the main cause of unsatisfactory treatment results in patients with this syndrome, leading to death in the postoperative period in 53-64% of cases (1,4,10). Significant violations of the functional state of the liver, the development of dystrophic and destructive transformation of hepatocytes, causing liver failure, develop in connection with insufficiently effective preoperative treatment	en_US
dc.publisher	Jundishapur Journal of Microbiology	en_US
dc.relation.ispartofseries	Vol. 15, No.2 (2022);
dc.title	Efficiency of Percutaneous Minimally Invasive Technologies in the Treatment of Patients with Obstructive Jaundice	en_US
dc.type	Article	en_US